Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Solid Tumor, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • David Thomas, PHD, FRACP

    Principal Investigator

    Omico; UNSW Sydney